{"name":"Impacts of COVID-19 on people with physical disabilities: a rapid review","id":"110","link":"https://www.sciencedirect.com/science/article/pii/S1936657420301461","dbsearches":"6","refs":"https://docs.google.com/spreadsheets/d/1bFmVeJFFWPwuj0ssJqKApYJN6d-cV3oUEjl6cvfCgdo/edit#gid=0","references":[{"doi":"10.1177/2396987320933746","date":"2020-05-15","title":"Maintaining stroke care in Europe during the COVID-19 pandemic:
Results from an international survey of stroke professionals and practice
recommendations from the European Stroke Organisation","abstract":"Introduction\nThe coronavirus disease 2019 (COVID-19) pandemic has been placing an\noverwhelming burden on health systems, thus threatening their ability to\noperate effectively for acute conditions in which treatments are highly time\nsensitive, such as cerebrovascular disorders and myocardial infarction.\n\n As\npart of an effort to reduce the consequences of this outbreak on health\nservice delivery to stroke patients, the European Stroke Organisation has\nundertaken a survey aimed at collecting information on the provision of\nstroke care during the pandemic.\n\n\nMethods\nCross-sectional, web-based survey, conducted from 26 March through 1 April\n2020 among stroke care providers, focused on reorganisation of health\nservices, the delivery of acute and post-acute stroke care and the\navailability of personal protective equipment.\n\n\nResults\nA total of 426 stroke care providers from 55 countries completed the survey,\nmost of whom worked in Europe (n?=?375, 88%) and were stroke\nphysicians/neurologists (n?=?334, 78%).\n\n Among European respondents, 289\n(77%) reported that not all stroke patients were receiving the usual care in\ntheir centres and 266 (71%) estimated that functional outcomes and\nrecurrence rates of stroke patients would be negatively affected by the\norganisational changes caused by the pandemic.\n\n The areas considered as being\nmost affected were acute care and rehabilitation.\n\n Most professionals had to\nadapt their activities and schedules and more than half reported shortage of\nprotective equipment.\n\n\nDiscussion\nStrategies to maintain availability of stroke care during the COVID-19\noutbreak are crucial to prevent indirect mortality and disability due to\nsuboptimal care.\n\n\nConclusion\nEuropean Stroke Organisation proposes a set of targeted actions for decision\nmakers facing this exceptional situation.\n\n\n","id":"PMC7538757","idformat":"PMC","foundapis":"_PMC_CROSSREF","miscinfo":"","authors":[{"firstname":"Diana","surname":"Aguiar de Sousa","email":"NULL","contributions":"1"},{"firstname":" H Bart","surname":"van der Worp","email":"NULL","contributions":"2"},{"firstname":" H Bart","surname":"van der Worp","email":"NULL","contributions":"0"},{"firstname":" Valeria","surname":"Caso","email":"NULL","contributions":"1"},{"firstname":" Charlotte","surname":"Cordonnier","email":"NULL","contributions":"1"},{"firstname":" Daniel","surname":"Strbian","email":"NULL","contributions":"2"},{"firstname":" Daniel","surname":"Strbian","email":"NULL","contributions":"0"},{"firstname":" George","surname":"Ntaios","email":"NULL","contributions":"1"},{"firstname":" Peter D","surname":"Schellinger","email":"NULL","contributions":"1"},{"firstname":" Else Charlotte","surname":"Sandset","email":"NULL","contributions":"1"},{"firstname":" NULL","surname":"NULL","email":"NULL","contributions":"0"},{"firstname":"                           NULL","surname":"NULL","email":"NULL","contributions":"0"}]},{"doi":"10.1016/j.dsx.2020.06.042","date":"2020-06-19","title":"Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals","abstract":"Routine care for chronic disease is an ongoing major challenge.\n\n We aimed to evaluate the global impact of COVID-19 on routine care for chronic diseases.\n\n An online survey was posted 31 March to 23 April 2020 targeted at healthcare professionals.\n\n 202 from 47 countries responded.\n\n Most reported change in routine care to virtual communication.\n\n Diabetes, chronic obstructive pulmonary disease, and hypertension were the most impacted conditions due to reduction in access to care.\n\n 80% reported the mental health of their patients worsened during COVID-19. It is important routine care continues in spite of the pandemic, to avoid a rise in non-COVID-19-related morbidity and mortality.\n\n","id":"PMC7308780","idformat":"PMC","foundapis":"_PMC_elsevier_CROSSREF","miscinfo":"","authors":[{"firstname":"Yogini V.","surname":"Chudasama","email":"NULL","contributions":"1"},{"firstname":" Clare L.","surname":"Gillies","email":"NULL","contributions":"1"},{"firstname":" Francesco","surname":"Zaccardi","email":"NULL","contributions":"0"},{"firstname":" Briana","surname":"Coles","email":"NULL","contributions":"1"},{"firstname":" Melanie J.","surname":"Davies","email":"NULL","contributions":"1"},{"firstname":" Samuel","surname":"Seidu","email":"NULL","contributions":"1"},{"firstname":"                           Kamlesh","surname":"Khunti","email":"NULL","contributions":"0"}]},{"doi":"10.1007/s00415-020-10099-9","date":"2020-07-20","title":"Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?","abstract":"Background\nAnxiety, depression and reduction of quality of life (QoL) are common in people with multiple sclerosis (pwMS).\n\n Fear of getting sick from COVID-19, government’s lockdown and the imposed social distancing might have had an impact on psychological distress and QoL.\n\n\nObjectives\nThe aim of our study was to investigate anxiety, depression and QoL changes in pwMS during SARS-CoV-2 outbreak and lockdown in Italy.\n\n\nMethods\n67 pwMS with a previous (less than 6 months) neuropsychological evaluation before SARS-CoV-2 outbreak (T0) were re-evaluated at the time of the outbreak and lockdown in Italy (T1).\n\n They underwent a clinical and neurological evaluation and completed the State-Trait Anxiety Inventory (STAI-Y1), the Beck Depression Inventory second edition (BDI-II), and Multiple Sclerosis Quality of Life-54 (MsQoL-54) at T0 and T1. Benjamini–Hochberg procedure was applied to control the false discovery rate.\n\n\nResults\nBDI-II and STAI-Y1 scores did not change between T0 and T1. At T1, MsQoL-54 scores were higher on the satisfaction with sexual life and the social function subscales, and lower on the limitation due to emotional problems subscale.\n\n\nConclusions\nThis is the first study that evaluated mood and QoL levels before and during the lockdown due to COVID-19 pandemic in pwMS.\n\n No worsening of anxiety and depression levels was found.\n\n Contrariwise some improvements were noted on QoL, the most reliable regarding the sexual satisfaction and the social function.\n\n\n","id":"PMC7385478","idformat":"PMC","foundapis":"_PMC_Springer_CROSSREF","miscinfo":"","authors":[{"firstname":"Rocco","surname":"Capuano","email":"NULL","contributions":"1"},{"firstname":" Manuela","surname":"Altieri","email":"NULL","contributions":"1"},{"firstname":" Alvino","surname":"Bisecco","email":"NULL","contributions":"1"},{"firstname":" Alessandro","surname":"d’Ambrosio","email":"NULL","contributions":"1"},{"firstname":" Renato","surname":"Docimo","email":"NULL","contributions":"1"},{"firstname":" Daniela","surname":"Buonanno","email":"NULL","contributions":"1"},{"firstname":" Federica","surname":"Matrone","email":"NULL","contributions":"1"},{"firstname":" Federica","surname":"Giuliano","email":"NULL","contributions":"1"},{"firstname":" Gioacchino","surname":"Tedeschi","email":"NULL","contributions":"1"},{"firstname":" Gabriella","surname":"Santangelo","email":"NULL","contributions":"1"},{"firstname":"                           Antonio","surname":"Gallo","email":"antonio.gallo@unicampania.it","contributions":"1"}]},{"doi":"10.1161/STROKEAHA.120.030225","date":"2020-05-05","title":"Impact of the COVID-19 Epidemic on Stroke Care and Potential Solutions","abstract":"Background and Purpose:\nWhen the coronavirus disease 2019 (COVID-19) outbreak became paramount, medical care for other devastating diseases was negatively impacted.\n\n In this study, we investigated the impact of the COVID-19 outbreak on stroke care across China.\n\n\nMethods:\nData from the Big Data Observatory Platform for Stroke of China consisting of 280 hospitals across China demonstrated a significant drop in the number of cases of thrombolysis and thrombectomy.\n\n We designed a survey to investigate the major changes during the COVID-19 outbreak and potential causes of these changes.\n\n The survey was distributed to the leaders of stroke centers in these 280 hospitals.\n\n\nResults:\nFrom the data of Big Data Observatory Platform for Stroke of China, the total number of thrombolysis and thrombectomy cases dropped 26.7% (P&lt;0.0001) and 25.3% (P&lt;0.0001), respectively, in February 2020 as compared with February 2019. We retrieved 227 valid complete datasets from the 280 stroke centers.\n\n Nearly 50% of these hospitals were designated hospitals for COVID-19. The capacity for stroke care was reduced in the majority of the hospitals.\n\n Most of the stroke centers stopped or reduced their efforts in stroke education for the public.\n\n Hospital admissions related to stroke dropped ?40%; thrombolysis and thrombectomy cases dropped ?25%, which is similar to the results from the Big Data Observatory Platform for Stroke of China as compared with the same period in 2019. Many factors contributed to the reduced admissions and prehospital delays; lack of stroke knowledge and proper transportation were significant limiting factors.\n\n Patients not coming to the hospital for fear of virus infection was also a likely key factor.\n\n\nConclusions:\nThe COVID-19 outbreak impacted stroke care significantly in China, including prehospital and in-hospital care, resulting in a significant drop in admissions, thrombolysis, and thrombectomy.\n\n Although many factors contributed, patients not coming to the hospital was probably the major limiting factor.\n\n Recommendations based on the data are provided.\n\n\n","id":"PMC7258753","idformat":"PMC","foundapis":"_PMC_CROSSREF","miscinfo":"","authors":[{"firstname":"Jing","surname":"Zhao","email":"NULL","contributions":"0"},{"firstname":" Hang","surname":"Li","email":"NULL","contributions":"1"},{"firstname":" David","surname":"Kung","email":"NULL","contributions":"1"},{"firstname":" Marc","surname":"Fisher","email":"NULL","contributions":"1"},{"firstname":" Ying","surname":"Shen","email":"NULL","contributions":"1"},{"firstname":"                           Renyu","surname":"Liu","email":"NULL","contributions":"1"}]},{"doi":"10.1007/s00415-020-10045-9","date":"2020-07-01","title":"Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices","abstract":"Objective\nTo report the understanding and decision-making of neuroimmunologists and their treatment of patients with multiple sclerosis (MS) during the early stages of the SARS-CoV-2 (COVID-19) outbreak.\n\n\nMethods\nA survey instrument was designed and distributed online to neurologists in April 2020.\nResults\nThere were 250 respondents (response rate 21.8%).\n\n 243 saw?&gt;??=?10 MS patients in the prior 6 months (average 197 patients) and were analyzed further (92% USA, 8% Canada; average practice duration 16 years; 5% rural, 17% small city, 38% large city, 40% highly urbanized).\n\n Patient volume dropped an average of 79% (53–11 per month).\n\n 23% were aware of patients self-discontinuing a DMT due to fear of COVID-19 with 43% estimated to be doing so against medical advice.\n\n 65% of respondents reported deferring?&gt;??=?1 doses of a DMT (49%), changing the dosing interval (34%), changing to home infusions (20%), switching a DMT (9%), and discontinuing DMTs altogether (8%) as a result of COVID-19. Changes in DMTs were most common with the high-efficacy therapies alemtuzumab, cladribine, ocrelizumab, rituximab, and natalizumab.\n\n 35% made no changes to DMT prescribing.\n\n 98% expressed worry about their patients contracting COVID-19 and 78% expressed the same degree of worry about themselves.\n\n ?&gt;?50% believed high-efficacy DMTs prolong viral shedding of SARS-CoV-2 and that B-cell therapies might prevent protective vaccine effects.\n\n Accelerated pace of telemedicine and practice model changes were identified as major shifts in practice.\n\n\nConclusions\nReported prescribing changes and practice disruptions due to COVID-19 may be temporary but could have a lasting influence on MS care.\n\n\nElectronic supplementary material\nThe online version of this article (10.1007/s00415-020-10045-9) contains supplementary material, which is available to authorized users.\n\n\n","id":"PMC7339100","idformat":"PMC","foundapis":"_PMC_Springer_CROSSREF","miscinfo":"","authors":[{"firstname":"Farrah J.","surname":"Mateen","email":"fmateen@mgh.harvard.edu","contributions":"1"},{"firstname":" Shawheen","surname":"Rezaei","email":"NULL","contributions":"2"},{"firstname":" Shawheen","surname":"Rezaei","email":"NULL","contributions":"0"},{"firstname":" Nicholas","surname":"Alakel","email":"NULL","contributions":"1"},{"firstname":" Brittany","surname":"Gazdag","email":"NULL","contributions":"1"},{"firstname":" Aditya Ravi","surname":"Kumar","email":"NULL","contributions":"1"},{"firstname":"                           Andre","surname":"Vogel","email":"NULL","contributions":"1"}]},{"doi":"10.1016/j.msard.2020.102380","date":"2020-07-05","title":"Attitudes of patients with relapsing-remitting form of multiple sclerosis using disease-modifying drugs in Montenegro regarding COVID-19 pandemic","abstract":"\n\n\n•\nMontenegrin MS patients worry about disease and future in the era of SARS-Cov2.","id":"PMC7341967","idformat":"PMC","foundapis":"_PMC_elsevier_CROSSREF","miscinfo":"","authors":[{"firstname":"Ljiljana","surname":"Radulovic","email":"NULL","contributions":"1"},{"firstname":" Jevto","surname":"Erakovic","email":"NULL","contributions":"1"},{"firstname":"                           Milovan","surname":"Roganovic","email":"NULL","contributions":"1"}]},{"doi":"10.1016/j.msard.2020.102407","date":"2020-07-16","title":"Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak","abstract":"\n\n\n•\nRRMS patients had different degrees of fear of COVID-19 disease.\n\n","id":"PMC7365115","idformat":"PMC","foundapis":"_PMC_elsevier_CROSSREF","miscinfo":"","authors":[{"firstname":"Aleksandar","surname":"Stojanov","email":"NULL","contributions":"1"},{"firstname":" Marina","surname":"Malobabic","email":"NULL","contributions":"1"},{"firstname":" Vuk","surname":"Milosevic","email":"NULL","contributions":"1"},{"firstname":" Jelena","surname":"Stojanov","email":"NULL","contributions":"1"},{"firstname":" Slobodan","surname":"Vojinovic","email":"NULL","contributions":"1"},{"firstname":" Goran","surname":"Stanojevic","email":"NULL","contributions":"1"},{"firstname":"                           Milos","surname":"Stevic","email":"NULL","contributions":"1"}]},{"doi":"10.3389/fneur.2020.00564","date":"2020-05-18","title":"An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients","abstract":"Objective: Neurological sequelae of SARS-CoV-2 infection have already been reported, but there is insufficient data about the impact of the pandemic on the management of the patients with chronic neurological diseases.\n\n We aim to analyze the effect of COVID-19 pandemic and social restriction rules on these fragile patients.\n\n","id":"PMC7273723","idformat":"PMC","foundapis":"_PMC_CROSSREF","miscinfo":"","authors":[{"firstname":"Carla","surname":"Piano","email":"NULL","contributions":"1"},{"firstname":" Enrico","surname":"Di Stasio","email":"NULL","contributions":"1"},{"firstname":" Guido","surname":"Primiano","email":"NULL","contributions":"1"},{"firstname":" Delfina","surname":"Janiri","email":"NULL","contributions":"1"},{"firstname":" Marco","surname":"Luigetti","email":"NULL","contributions":"1"},{"firstname":" Giovanni","surname":"Frisullo","email":"NULL","contributions":"1"},{"firstname":" Catello","surname":"Vollono","email":"NULL","contributions":"1"},{"firstname":" Matteo","surname":"Lucchini","email":"NULL","contributions":"1"},{"firstname":" Valerio","surname":"Brunetti","email":"NULL","contributions":"1"},{"firstname":" Mauro","surname":"Monforte","email":"NULL","contributions":"1"},{"firstname":" Valeria","surname":"Guglielmi","email":"NULL","contributions":"1"},{"firstname":" Giacomo","surname":"Della Marca","email":"NULL","contributions":"1"},{"firstname":" Amelia","surname":"Evoli","email":"NULL","contributions":"1"},{"firstname":" Camillo","surname":"Marra","email":"NULL","contributions":"1"},{"firstname":" Massimiliano","surname":"Mirabella","email":"NULL","contributions":"1"},{"firstname":" Davide","surname":"Quaranta","email":"NULL","contributions":"1"},{"firstname":" Enzo","surname":"Ricci","email":"NULL","contributions":"1"},{"firstname":" Serenella","surname":"Servidei","email":"NULL","contributions":"1"},{"firstname":" Gabriella","surname":"Silvestri","email":"NULL","contributions":"1"},{"firstname":" Simone","surname":"Bellavia","email":"NULL","contributions":"1"},{"firstname":" Sara","surname":"Bortolani","email":"NULL","contributions":"1"},{"firstname":" Francesco","surname":"Bove","email":"NULL","contributions":"1"},{"firstname":" Riccardo","surname":"Di Iorio","email":"NULL","contributions":"1"},{"firstname":" Andrea","surname":"Di Paolantonio","email":"NULL","contributions":"1"},{"firstname":" Danilo","surname":"Genovese","email":"NULL","contributions":"1"},{"firstname":" Tamara","surname":"Ialongo","email":"NULL","contributions":"1"},{"firstname":" Maria Rita","surname":"Lo Monaco","email":"NULL","contributions":"1"},{"firstname":" Jessica","surname":"Marotta","email":"NULL","contributions":"1"},{"firstname":" Agata Katia","surname":"Patanella","email":"NULL","contributions":"1"},{"firstname":" Alessia","surname":"Perna","email":"NULL","contributions":"1"},{"firstname":" Martina","surname":"Petracca","email":"NULL","contributions":"1"},{"firstname":" Giorgia","surname":"Presicce","email":"NULL","contributions":"1"},{"firstname":" Vittorio","surname":"Riso","email":"NULL","contributions":"1"},{"firstname":" Eleonora","surname":"Rollo","email":"NULL","contributions":"1"},{"firstname":" Angela","surname":"Romano","email":"NULL","contributions":"1"},{"firstname":" Marina","surname":"Romozzi","email":"NULL","contributions":"1"},{"firstname":" Cristina","surname":"Sancricca","email":"NULL","contributions":"1"},{"firstname":" Irene","surname":"Scala","email":"NULL","contributions":"1"},{"firstname":" Gregorio","surname":"Spagni","email":"NULL","contributions":"1"},{"firstname":" Marcella","surname":"Solito","email":"NULL","contributions":"1"},{"firstname":" Luca","surname":"Tricoli","email":"NULL","contributions":"1"},{"firstname":" Paola","surname":"Zinzi","email":"NULL","contributions":"1"},{"firstname":" Paolo","surname":"Calabresi","email":"NULL","contributions":"1"},{"firstname":"                           Anna Rita","surname":"Bentivoglio","email":"NULL","contributions":"1"}]},{"doi":"10.1080/21678421.2020.1773502","date":"1970-01-01","title":"Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy","abstract":"Background: Teleneurology is an effective tool for the rapid evaluation of patients in remote locations with a well-established use in stroke and epilepsy.\n To date its adoption for Amyotrophic Lateral Sclerosis (ALS) care is still in a preliminary stage.\n We evaluated the feasibility of multidisciplinary assessment of patients with ALS, using telememedicine during the emergency determined by the COVID-19 pandemic.\n Methods: All patients included in this survey had received a diagnosis of ALS according to international criteria after a complete clinical and paraclinical assessment during 2019. A structured questionnaire was used by the neurologist with the patient or the caregiver.\n A video interaction was offered but refused by all patients because they did not feel comfortable or did not have smartphone.\n Results: Out of 31 clinical interviews 8 were completed directly with the patients and 23 with patients\u2019 caregivers.\n In a successive survey, most of patients were satisfied with the neurological interview (85%), the possibility to interact directly with the clinician being at home (85%) and reduction of economic and time costs because they avoided unnecessary travel to the clinic.\n Most of subjects expressed their willingness to continue to be included in remote evaluation programs (90%).\n Notably, none of the patients presented index symptoms of Covid-19 infection.\n Conclusion: Our study indicates that telemedicine is a valid tool to triage patients with ALS to increase practice outreach and efficiency.\n Delivery of care via telemedicine was effective and successful in people with ALS in the dramatic and sudden crisis determined by Covid-19 outbreak","id":"10.1080/21678421.2020.1773502","idformat":"CORE","foundapis":"_CROSSREF","miscinfo":"","authors":[{"firstname":"Accogli","surname":"M.","email":"coreGivesNoEmail","contributions":"1"},{"firstname":" Barone","surname":"R.","email":"coreGivesNoEmail","contributions":"1"},{"firstname":" Capozzo","surname":"R.","email":"coreGivesNoEmail","contributions":"1"},{"firstname":" Logroscino","surname":"G.","email":"coreGivesNoEmail","contributions":"1"},{"firstname":" Musio","surname":"M.","email":"coreGivesNoEmail","contributions":"1"},{"firstname":"                         Zoccolella","surname":"S.","email":"coreGivesNoEmail","contributions":"1"}]},{"doi":"10.1007/s00415-020-10064-6","date":"2020-07-06","title":"Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine","abstract":"Background\nQuarantine was the measure taken by governments to control the rapid spread of COVID-19. This restriction resulted in a sudden change in people’s lifestyle, leading to an increase in sedentary behavior and a related decrease in the practice of physical activity (PA).\n\n However, in neuromuscular diseases patients need to perform regular PA to counteract the negative consequences of the disease.\n\n Hence, the aim of this study was to estimate the levels of PA, measured as energy expenditure (MET–minute/week), among patients with neuromuscular disease (NMD) before and during the last week of quarantine.\n\n\nMethods\nA total of 268 Italian subjects, living in Sicily, completed an adapted version of the IPAQ-SF.\n\n Participants comprised 149 NMD, enrolled at the Neuromuscular Clinic of Palermo and 119 healthy subjects (control group).\n\n The SF-12 questionnaire was also administered to NMD.\n\n The Mann–Whitney U and the Kruskal–Wallis rank-sum tests were used for statistical analyses.\n\n\nResults\nWe observed a significant decrease of the total weekly PA level during COVID-19 quarantine in both patients and controls.\n\n Moreover, a significant difference in the total weekly PA level was found depending on the presence of neuromuscular disease, impaired walking, gender and BMI.\n\n Finally, we found a correlation between SF-12 scores and the entity of the reduction of PA level during quarantine, thus confirming a relevant association with the quality of life in NMD.\n\n\nConclusion\nOur study confirmed that COVID-19 quarantine has affected the practice of PA among both NMD and healthy controls.\n\n\n","id":"PMC7356123","idformat":"PMC","foundapis":"_PMC_Springer_CROSSREF","miscinfo":"","authors":[{"firstname":"Vincenzo","surname":"Di Stefano","email":"vincenzo19689@gmail.com","contributions":"1"},{"firstname":" Giuseppe","surname":"Battaglia","email":"NULL","contributions":"2"},{"firstname":" Giuseppe","surname":"Battaglia","email":"NULL","contributions":"0"},{"firstname":" Valerio","surname":"Giustino","email":"NULL","contributions":"1"},{"firstname":" Andrea","surname":"Gagliardo","email":"NULL","contributions":"1"},{"firstname":" Michele","surname":"D’Aleo","email":"NULL","contributions":"1"},{"firstname":" Ottavio","surname":"Giannini","email":"NULL","contributions":"1"},{"firstname":" Antonio","surname":"Palma","email":"NULL","contributions":"1"},{"firstname":"                           Filippo","surname":"Brighina","email":"NULL","contributions":"1"}]},{"doi":"10.1093/eurpub/ckaa159","date":"2020-07-29","title":"Comparison of physical activity levels in Spanish adults with chronic conditions before and during COVID-19 quarantine","abstract":"Background\nThis is the first study analysing levels of physical activity in a sample of quarantined adults with chronic conditions.\n\n The aim of this study was to compare moderate-intensity and vigorous-intensity physical activity levels in Spanish adults with chronic conditions before and during COVID-19 quarantine.\n\n\nMethods\nA cross-sectional online survey was administered during the COVID-19 quarantine in Spain.\n\n A total of 163 participants with chronic conditions (113 females and 47 males; age range 18-64 years) completed the survey.\n\n A total of 26 chronic conditions were included.\n\n Participants self-reported average minutes/day of moderate and vigorous physical activity before and during quarantine.\n\n Differences in moderate-intensity physical activity and vigorous-intensity physical activity levels before and during COVID-19 quarantine (overall, by gender, by age, by number of chronic conditions and by each chronic condition) were assessed by Wilcoxon signed-rank test.\n\n\nResults\nDuring COVID-19 quarantine, there was a significant decrease of moderate-intensity physical activity in Spanish people with chronic conditions (in both males and females, in those aged 18-24, 25-34, 35-44 and 55-64 years, in those with multimorbidity, in those with one/two chronic condition/s, and in those diagnosed with asthma/hypercholesterolemia/chronic skin disease/hemorrhoids).\n\n Also, there was a significant decrease of vigorous-intensity physical activity in Spanish males with chronic conditions and in those with multimorbidity.\n\n\nConclusions\nThese results should be considered to develop effective strategies of physical activity promotion targeting these specific groups when new quarantine or restriction measures are implemented, in order to avoid new significant decreases of physical activity in these vulnerable populations.\n\n\n","id":"PMC7454536","idformat":"PMC","foundapis":"_PMC_CROSSREF","miscinfo":"","authors":[{"firstname":"Guillermo F","surname":"López-Sánchez","email":"gfls@um.es","contributions":"1"},{"firstname":" Rubén","surname":"López-Bueno","email":"rlopezbu@unizar.es","contributions":"1"},{"firstname":" Alejandro","surname":"Gil-Salmerón","email":"alejandro.gil.salmeron@uv.es","contributions":"1"},{"firstname":" Roksana","surname":"Zauder","email":"NULL","contributions":"1"},{"firstname":" Maria","surname":"Skalska","email":"NULL","contributions":"1"},{"firstname":" Joanna","surname":"Jastrz?bska","email":"NULL","contributions":"1"},{"firstname":" Zbigniew","surname":"Jastrz?bski","email":"NULL","contributions":"1"},{"firstname":" Felipe B","surname":"Schuch","email":"NULL","contributions":"1"},{"firstname":" Igor","surname":"Grabovac","email":"NULL","contributions":"1"},{"firstname":" Mark A","surname":"Tully","email":"NULL","contributions":"1"},{"firstname":"                           Lee","surname":"Smith","email":"NULL","contributions":"0"}]}]}